all report title image

BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Biologics Contract Manufacturing Market, By Service Type (Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing, Drug product/Formulation and Fill-Finish (FDF), Analytical and Quality Control services, Process development and scale-up/Technology transfer, and Packaging, labeling and ancillary services), By Biologic Type (Monoclonal antibodies (mAbs), Recombinant proteins and enzymes, Vaccines, Cell and gene therapies, Antibody-drug conjugates (ADCs), and Others (growth factors, cytokines, fusion proteins)), By Production System (Mammalian systems (CHO, NS0, HEK), Microbial systems (E. coli, yeast), and Alternative/Emerging systems (insect cells, plant, cell-free)), By Scale (Preclinical/clinical scale manufacturing and Commercial scale manufacturing), By Company Size (Small to Mid-sized Contract Manufacturers and Large Contract Manufacturing Organizations (CMOs/CDMOs)), By Therapeutic Area (Oncology/Hematology, Immunology and Autoimmune Disorders, Infectious Diseases and Vaccinology, Cardiovascular and Renal Disorders, Neurology and Central Nervous System (CNS) Disorders, Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid), Respiratory Disorders, and Others (Dermatology, Rare and Orphan Diseases)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 17 Mar, 2026
  • Code: CMI8662
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Biotechnology
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Biologics Contract Manufacturing Market, By Service Type
      • Global Biologics Contract Manufacturing Market, By Biologic Type
      • Global Biologics Contract Manufacturing Market, By Production System
      • Global Biologics Contract Manufacturing Market, By Scale
      • Global Biologics Contract Manufacturing Market, By Company Size
      • Global Biologics Contract Manufacturing Market, By Therapeutic Area
      • Global Biologics Contract Manufacturing Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Biologics Contract Manufacturing Market, By Service Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Drug product/Formulation and Fill-Finish (FDF)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Analytical and Quality Control services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Process development and scale-up/Technology transfer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Packaging, labeling and ancillary services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Biologics Contract Manufacturing Market, By Biologic Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monoclonal antibodies (mAbs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Recombinant proteins and enzymes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cell and gene therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Antibody-drug conjugates (ADCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (growth factors, cytokines, fusion proteins)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Biologics Contract Manufacturing Market, By Production System, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Mammalian systems (CHO, NS0, HEK)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Microbial systems (E. coli, yeast)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Alternative/Emerging systems (insect cells, plant, cell-free)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Biologics Contract Manufacturing Market, By Scale, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Preclinical/clinical scale manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Commercial scale manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Biologics Contract Manufacturing Market, By Company Size, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Small to Mid-sized Contract Manufacturers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Large Contract Manufacturing Organizations (CMOs/CDMOs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Biologics Contract Manufacturing Market, By Therapeutic Area, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology/Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Immunology and Autoimmune Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Infectious Diseases and Vaccinology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cardiovascular and Renal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Neurology and Central Nervous System (CNS) Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Dermatology, Rare and Orphan Diseases)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Biologics Contract Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Catalent
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Samsung Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim BioXcellence
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fujifilm Diosynth Biotechnologies
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AGC Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Recipharm
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siegfried
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rentschler Biopharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abzena
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • IDT Biologika
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Avid Bioservices
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About Us

*Browse 32 market data tables and 28 figures on 'Biologics Contract Manufacturing Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.